Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02656212 · ClinicalTrials.gov registry record · Phase 1
Early Phase Pre-Clinical and Initial Clinical Research on Epicatechin (Part 2)
A Phase 1 study, sponsored by Veterans Medical Research Foundation.
- Completed
- Registry status
- Phase 1
- Development phase
- 15
- Enrollment target
NCT02656212 is a Phase 1 study that has completed, run by Veterans Medical Research Foundation. The registered enrollment target is 15 participants.
The verdict
NCT02656212, a Phase 1 study, has completed, sponsored by Veterans Medical Research Foundation.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 15 participants
- Enrollment target
Study Summary
This will be a double-blind, randomized, placebo-controlled, single dose study of (+)- epicatechin with one 30mg dose/day for a total of 7 days
Interventions
- DRUG Placebo
- DRUG epicatechin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2015-09 |
| Est. Completion | 2016-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02656212
The ClinicalTrials.gov registry entry for NCT02656212 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Veterans Medical Research Foundation, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02656212 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02656212 about?
NCT02656212 is a clinical study titled "Early Phase Pre-Clinical and Initial Clinical Research on Epicatechin (Part 2)". This will be a double-blind, randomized, placebo-controlled, single dose study of (+)- epicatechin with one 30mg dose/day for a total of 7 days
What is the current status of trial NCT02656212?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 15 participants. The study started on 2015-09. Estimated completion is 2016-04.
What interventions are being tested in trial NCT02656212?
The interventions under investigation include: Placebo (DRUG), epicatechin (DRUG).
Who is sponsoring clinical trial NCT02656212?
This trial is sponsored by Veterans Medical Research Foundation, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.